Businesses around the world have been substantially impacted by the COVID-19 pandemic and are likely to be managing the effects and remaining uncertainties for some time. In this context, we expect to see a shift in risk allocation in the European private M&A market to deal protection mechanisms more synonymous with a buyer’s market and specific provision for COVID-19, such as tailored warranties and covenants.